Multi-session electrical neuromodulation effects on craving, relapse and cognitive functions in cocaine use disorder: A randomized, sham-controlled tDCS study

被引:10
|
作者
Verveer, Ilse [1 ]
van der Veen, Frederik M. [1 ]
Shahbabaie, Alireza [2 ]
Remmerswaal, Danielle [1 ]
Franken, Ingmar H. A. [1 ]
机构
[1] Erasmus Univ, Erasmus Sch Social & Behav Sci, Dept Psychol Educ & Child Studies, Rotterdam, Netherlands
[2] Leiden Univ, Inst Psychol, Cognit Psychol Unit, Leiden, Netherlands
关键词
Cocaine use disorder; tDCS; Relapse; Inhibitory control; Go-NoGo; Risky decision-making; DIRECT-CURRENT STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; DECISION-MAKING; MODULATION; DYSFUNCTION; EFFICACY; TRIAL;
D O I
10.1016/j.drugalcdep.2020.108429
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The use of transcranial Direct Current Stimulation (tDCS) has previously shown promising results for reducing craving in cocaine use disorder. In this study we further explored the potential of tDCS as add-on intervention in the treatment of cocaine use disorder. Methods: In a randomized, placebo-controlled, between subject study, we applied tDCS bilaterally with the anodal electrode targeting the right dorsolateral prefrontal cortex (DLPFC; https://clinicaltrials.gov/ct2/show/NCT03025321). Patients with cocaine use disorder were allocated to ten sessions of either active tDCS (n = 29) or sham (n = 30) on five consecutive days. Inhibitory control and risky decision-making were measured via a Go-NoGo task and a two-choice gambling task, respectively, each at baseline, one day after all tDCS sessions and after three months. Relapse at follow-up and craving were also assessed. Results: There was no significant effect of active tDCS on the number of cocaine use days and craving. Relapse was frequent among patients who had received either active or sham tDCS (48.0 % and 69.2 %, respectively), despite an overall decrease in craving during the first two weeks of treatment. No effects were found on cognitive functions. An exploratory analysis for crack cocaine use only revealed that relapse rates were significantly reduced after active tDCS (n = 17) as compared to sham (n = 19). Conclusions: No beneficial effects of tDCS on number of cocaine use days, craving and cognitive functions were found in the present study, but somewhat promising results were obtained regarding relapse rates among crack-cocaine users specifically. Further research is required to determine the efficacy of tDCS as a complementary treatment in cocaine use disorder.
引用
收藏
页数:8
相关论文
共 43 条
  • [41] A study protocol for an ongoing multi-arm, randomized, double-blind, sham-controlled clinical trial with digital features, using portable transcranial electrical stimulation and internet-based behavioral therapy for major depression disorders: The PSYLECT study
    Borrione, Lucas
    Cirillo, Patricia C.
    Aparicio, Luana V. M.
    Cavendish, Beatriz A.
    Valiengo, Leandro
    Moura, Darin O.
    de Souza, Juliana P.
    Luethi, Matthias S.
    Klein, Izio
    Bariani, Bruna
    Gallucci-Neto, Jose
    Suen, Paulo
    Padberg, Frank
    Goerigk, Stephan
    Vanderhasselt, Marie-Anne
    De Deng, Zhi
    O'Shea, Jacinta
    Lotufo, Paulo A.
    Bensenor, Isabela M.
    Brunoni, Andre R.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2022, 22 (06) : 513 - 523
  • [42] The effects of transcranial direct current stimulation on attention and inhibitory control of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) Study protocol for a randomized, sham-controlled, triple-blind, cross-over trial
    Quadros Guimaraes, Rachel Silvany
    Bandeira, Igor D.
    Barretto, Bianca Lima
    Barretto, Thiago Lima
    Wanke, Thamires
    Carvalho Alves, Clara Oliveira
    de Carvalho, Chrissie Ferreira
    Lucena, Pedro H.
    Rodrigues-Silva, Luciana
    Lucena, Rita
    MEDICINE, 2021, 100 (08) : E24283
  • [43] Phase-IIa randomized, double-blind, sham-controlled, parallel group trial on anodal transcranial direct current stimulation (tDCS) over the left and right tempo-parietal junction in autism spectrum disorder-StimAT: study protocol for a clinical trial
    Luckhardt, Christina
    Schutz, Magdalena
    Muhlherr, Andreas
    Moessinger, Hannah
    Boxhoorn, Sara
    Dempfle, Astrid
    Salvador, Ricardo
    Ruffini, Giulio
    Pereira, Helena C.
    Castelo-Branco, Miguel
    Latinus, Marianne
    Bonnet-Brilhault, Frederique
    Siemann, Julia
    Siniatchkin, Michael
    Ecker, Christine
    Freitag, Christine M.
    TRIALS, 2021, 22 (01)